Another class of drugs used to treat hyperphosphatemia and hyperparathyroidism are calcimimetics, including Cinacalcet, which acts by allosterically activating the calcium-sensing receptor (CaSR) [136,137,138]. Here, CASR is linked to hyperphosphatemia.